SHANGHAI – Shanghai-based Ark Biosciences Inc., a virtual biotech, and the California Institute of Biomedical Research (Calibr), of La Jolla, an affiliate of The Scripps Research Institute (TSRI), one of the world's largest private biomedical research institutes, have partnered to develop preclinical assets for chronic obstructive pulmonary disease (COPD).